Evidence map›Paper›PMID 17892322›Full record

ArticlePLoS pathogens2007

Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.

Deborah A Lewinsohn, Ervina Winata, Gwendolyn M Swarbrick, Katie E Tanner, Matthew S Cook, Megan D Null, Meghan E Cansler, Alessandro Sette, John Sidney, David M Lewinsohn

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02687529 (Evaluation of the 4th Generation QuantiFERON-TB Test), which is not on this map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02687529 completednot on this mapstarted 2015, after this paper: background citation

Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection

TypeobservationalSponsorQIAGEN Gaithersburg, IncRan2015 to 2016Enrolled66ConditionsTuberculosisArmsCST001
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 158 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Immunodominant Tuberculosis Antigens Recognized by Human CD4Cold Spring Harbor perspectives in medicine · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. CD8+ lymphocytes in immunity against tuberculosis.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  11. Review
  12. Sorting endosomes play key roles in presentation ofbioRxiv : the preprint server for biology · 2025
    Article
  13. Control of antigen presentation on MHC-I by a bacterial secretion system.bioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Deborah A LewinsohnDepartment of Pediatrics, Oregon Health and Sciences University, Portland, Oregon, USA.
Ervina Winata
Gwendolyn M Swarbrick
Katie E Tanner
Matthew S Cook
Megan D Null
Meghan E Cansler
Alessandro Sette
John Sidney
David M Lewinsohn
Oregon Health & Science University · USLa Jolla Institute for Immunology · US

Funding

Recognition of Mtb-infected Cells by CD8+ T LymphocytesR01AI048090 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2001 to 2016
$4.2M
Tuberculosis Immunity in Young ChildrenR01AI054474 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DEBORAH A. · 2003 to 2006
$1.3M
NIAID NIH HHS R01 AI048090NIAID NIH HHS R01 AI054474NIAID NIH HHS R01AI054474NIAID NIH HHS R01AI48090PHS HHS N01-A1-400081
6 · The paper itself

Abstract

CD8(+) T cells are essential for host defense to intracellular bacterial pathogens such as Mycobacterium tuberculosis (Mtb), Salmonella species, and Listeria monocytogenes, yet the repertoire and dominance pattern of human CD8 antigens for these pathogens remains poorly characterized. Tuberculosis (TB), the disease caused by Mtb infection, remains one of the leading causes of infectious morbidity and mortality worldwide and is the most frequent opportunistic infection in individuals with HIV/AIDS. Therefore, we undertook this study to define immunodominant CD8 Mtb antigens. First, using IFN-gamma ELISPOT and synthetic peptide arrays as a source of antigen, we measured ex vivo frequencies of CD8(+) T cells recognizing known immunodominant CD4(+) T cell antigens in persons with latent tuberculosis infection. In addition, limiting dilution was used to generate panels of Mtb-specific T cell clones. Using the peptide arrays, we identified the antigenic specificity of the majority of T cell clones, defining several new epitopes. In all cases, peptide representing the minimal epitope bound to the major histocompatibility complex (MHC)-restricting allele with high affinity, and in all but one case the restricting allele was an HLA-B allele. Furthermore, individuals from whom the T cell clone was isolated harbored high ex vivo frequency CD8(+) T cell responses specific for the epitope, and in individuals tested, the epitope represented the single immunodominant response within the CD8 antigen. We conclude that Mtb-specific CD8(+) T cells are found in high frequency in infected individuals and are restricted predominantly by HLA-B alleles, and that synthetic peptide arrays can be used to define epitope specificities without prior bias as to MHC binding affinity. These findings provide an improved understanding of immunodominance in humans and may contribute to a development of an effective TB vaccine and improved immunodiagnostics.

Indexed as

AllelesAntigens, BacterialCD4-Positive T-LymphocytesCD8 AntigensCD8-Positive T-LymphocytesCell LineHLA-B AntigensHumansImmunodominant EpitopesMycobacterium tuberculosisTuberculosisAntigens, BacterialCD8 AntigensHLA-B AntigensImmunodominant Epitopes

Identifiers

PMID17892322
PMCPMC2323292
OpenAlexW2067327881

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.